Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for TriSalus Life Sciences (TLSIW) over the last 3 years, with Q3 2025 value amounting to -$177000.0.

  • TriSalus Life Sciences' Amortizatization of Intangibles fell 31851.85% to -$177000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $778000.0, marking a year-over-year increase of 15508.2%. This contributed to the annual value of $604000.0 for FY2024, which is 19900.99% up from last year.
  • According to the latest figures from Q3 2025, TriSalus Life Sciences' Amortizatization of Intangibles is -$177000.0, which was down 31851.85% from $318000.0 recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Amortizatization of Intangibles registered a high of $371000.0 during Q4 2024, and its lowest value of -$177000.0 during Q3 2025.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $76000.0 (2024), whereas its average is $110272.7.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first skyrocketed by 79090.91% in 2024, then tumbled by 31851.85% in 2025.
  • Over the past 3 years, TriSalus Life Sciences' Amortizatization of Intangibles (Quarter) stood at $72000.0 in 2023, then soared by 415.28% to $371000.0 in 2024, then plummeted by 147.71% to -$177000.0 in 2025.
  • Its Amortizatization of Intangibles stands at -$177000.0 for Q3 2025, versus $318000.0 for Q2 2025 and $266000.0 for Q1 2025.